<DOC>
	<DOCNO>NCT00848562</DOCNO>
	<brief_summary>Survival invasive coronary revascularization worse patient chronic kidney disease without . The investigator aim examine whether oral administration nicorandil , hybrid nitrate adenosine triphosphate-sensitive potassium channel opener , could improve survival end-stage renal disease patient coronary artery disease inhibit cardiac death coronary revascularization .</brief_summary>
	<brief_title>Nicorandil Study Reduce Cardiac Death After Percutaneous Coronary Intervention ( PCI ) Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Nicorandil</mesh_term>
	<criteria>Hemodialysis patient coronary artery disease undergone successful first PCI baremetal stent July 1 , 2001 December 31 , 2003 . Subjects moderate bad cardiac valvular disease old myocardial infarction point first PCI .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>sudden cardiac death</keyword>
</DOC>